# BAXDELA
> **NDA208610** · New Drug Application · Sponsor: MELINTA · Approved 2017-06-19
## Drug
- **FDA Application Number:** NDA208610
- **Application type:** New Drug Application
- **Brand name:** BAXDELA
- **Generic name:** DELAFLOXACIN MEGLUMINE
- **Active ingredients:** DELAFLOXACIN MEGLUMINE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** MELINTA
- **Manufacturer:** Melinta Therapeutics, LLC
- **First approval:** 2017-06-19
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208610)
---
*AI Analytics · CC0 1.0*